Dr. Wouter Leemans Neurologie: what changed
Dr. Wouter Leemans Neurologie
Largest movements
- Cash +€75,637
up €75,637 (+142%), from €53,313 to €128,951
mainly Net result for the year (+€70,559) and Tax, wage and social debts (+€6,847)
- Reserves +€70,559
up €70,559 (+164%), from €43,071 to €113,630
- Tax, wage and social debts +€6,847
up €6,847 (+61.8%), from €11,087 to €17,934
- Gross operating margin +€34,503
up €34,503 (+63.5%), from €54,295 to €88,798
- Taxes +€6,847
up €6,847 (+61.8%), from €11,087 to €17,934
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €59,241 | €136,486 | +€77,246 | +130% |
| Fixed assets | 21/28 | - | €1,200 | +€1,200 | |
| Financial fixed assets | 28 | - | €1,200 | +€1,200 | |
| Current assets | 29/58 | €59,241 | €135,286 | +€76,046 | +128% |
| Amounts receivable within one year | 40/41 | - | €9 | +€9 | |
| Other amounts receivable | 41 | - | €9 | +€9 | |
| Cash at bank and in hand | 54/58 | €53,313 | €128,951 | +€75,637 | +142% |
| Deferred charges and accrued income | 490/1 | €5,927 | €6,327 | +€399 | +6.7% |
| Total equity and liabilities | 10/49 | €59,241 | €136,486 | +€77,246 | +130% |
| Equity | 10/15 | €46,071 | €116,630 | +€70,559 | +153% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €43,071 | €113,630 | +€70,559 | +164% |
| Distributable reserves | 133 | €43,071 | €113,630 | +€70,559 | +164% |
| Amounts payable | 17/49 | €13,170 | €19,857 | +€6,687 | +50.8% |
| Amounts payable within one year | 42/48 | €13,170 | €19,857 | +€6,687 | +50.8% |
| Financial debts | 43 | €603 | €0 | -€603 | -100% |
| Credit institutions | 430/8 | €603 | €0 | -€603 | -100% |
| Trade debts | 44 | €1,480 | €1,923 | +€442 | +29.9% |
| Suppliers | 440/4 | €1,480 | €1,923 | +€442 | +29.9% |
| Taxes, remuneration and social security | 45 | €11,087 | €17,934 | +€6,847 | +61.8% |
| Taxes | 450/3 | €11,087 | €17,934 | +€6,847 | +61.8% |
| Other operating charges | 640/8 | €118 | €210 | +€92 | +78.0% |
| Gross operating margin | 9900 | €54,295 | €88,798 | +€34,503 | +63.5% |
| Operating profit (loss) | 9901 | €54,177 | €88,588 | +€34,411 | +63.5% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €19 | €95 | +€76 | +400% |
| Recurring financial charges | 65 | €19 | €95 | +€76 | +400% |
| Profit (loss) for the period before taxes | 9903 | €54,158 | €88,493 | +€34,336 | +63.4% |
| Income taxes | 67/77 | €11,087 | €17,934 | +€6,847 | +61.8% |
| Profit (loss) for the period | 9904 | €43,071 | €70,559 | +€27,488 | +63.8% |
| Profit (loss) for the period to be appropriated | 9905 | €43,071 | €70,559 | +€27,488 | +63.8% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.